Clinical trial
An Investigational Drug Study in the Treatment of Primary Dysmenorrhea…
NCT00092729 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00092729 |
|---|---|
| Title | An Investigational Drug Study in the Treatment of Primary Dysmenorrhea (0663-064) |
| Official title | A Randomized, Placebo-and Active-Comparator-Controlled Study of Etoricoxib 120 mg in the Treatment of Primary Dysmenorrhea |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Dysmenorrhea |
| Intervention type | Drug |
| Interventions | etoricoxib (MK0663), Comparator: placebo (unspecified), Comparator: naproxen sodium |
| Enrollment | 129 |
| Start date | Jun 7, 2002 |
| Primary completion | Dec 6, 2002 |
| Completion | Dec 6, 2002 |
| First posted | Sep 28, 2004 |
| Last update posted | Aug 15, 2024 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: